Skip to main content

Postgraduate Positions

 

The following projects are self-funding. Postgraduate applications must be made using the online application portal

In order to apply, please follow the link via the project title in which you are interested. Applicants should have a 1st or 2.1 honours degree (or equivalent) in a relevant subject. Students who have a 2.2 honours degree and a Master’s degree may also be considered, but the School reserves the right to shortlist for interview only those applicants who have demonstrated high academic attainment to date. Students are advised to apply for more than one project

 

 

Synthesis and evaluation of Co-enzyme-A derivatives to probe the role of acyl Co-A in diseases and ageing. - Dr Marie Migaud and Professor Tracy Robson

Synthesis and evaluation of tetrahydrofolate derivatives to probe the role of folate supplementation in the incorporation of errors in DNA. - Dr Marie Migaud and Dr Helen McCarthy

Delivery of cathepsin inhibitors using targeted nanoparticle strategies - Prof Christopher Scott, Dr Roberta Burden and Dr Rich Williams

Application of novel anti-flammatory nanoparticles using microneedle arrays for the treatment of psoriasis - Prof Christopher Scott and Prof Ryan Donnelly

Targeting microRNAs as diagnostic and therapeutic solutions for chemoresistant epithelial ovarian cancer (EOC) - Dr Fiona Furlong and Prof Tracy Robson

Enhanced radiosensitivity of prostate cancer using targeted gold nanoparticles - Dr Jonathan Coulter and Dr Helen McCarthy

Identifying and targeting prostate tumour initiating cells to achieve enhanced tumour control - Dr Jonathan Coulter and Professor Tracy Robson

Ultrashort self-assembling peptides/peptidomimetics as antimicrobial biomaterials - Dr Garry Laverty, Dr Brendan Gilmore and Prof David Jones

Ultrashort self-assembling peptides/peptidomimetics as ocular drug delivery vehicles - Dr Garry Laverty, Dr Thakur R.R. Singh and Prof David Jones

Lipsomal delivery of antibiotics for treatment of pulmonary infection - Dr Vicky Kett, Prof Michael Tunney, Prof S Elborn (Centre for Infection & Immunity)

Targeting trysin-like proteases in cystic fibrosis airways as a mechanism to restore mucociliary function - Dr Lorraine Martin, Prof Brian Walker and Prof S Elborn

Investigation of dipeptidyl peptidase I (cathepsin C) as a pivotal mediator in the progression of inflammatory lung disease - Dr Lorraine Martin and Prof Brian Walker

Materials with improved biocompatibility for implantable medical devices - Dr Louise Carson and Prof Colin McCoy

Profiling the proteolytic events involved in foreign body giant cell formation and the foreign body response to biomaterials - Dr Louise Carson and Dr Brendan Gilmore

Prescribing in palliative care - Dr Carole Parsons and Prof Carmel Hughes

Medication use in patients with dementia - Dr Carole Parsons and Prof Carmel Hughes

Elucidation of mechanisms regulating CCL2 expression - Dr Roberta Burden, Prof Chris Scott and Dr Paul Mullan

The role of MRSA in cystic fibrosis (CF) lung infection - Dr Deirdre Gilpin, Prof Michael Tunney and Prof Stuart Elborn

A genomic appraoch to determining antibiotic resistance and virulence among Pseudomonas aeruginosa isolates from Cystic Fibrosis - Dr D Gilpin, Prof M Tunney and Prof S Elborn (Centre for Infection and Immunity)

Effect of Ivacaftor on airway microbial community composition in patients with Cystic Fibrosis - Prof Michael Tunney, Dr Deirdre Gilpin, Prof S Elborn (Centre for Infection and Immunity)

Microbial community composition in the Cystic Fibrosis (CF) lung: effect on structural damage and disease progression - Prof Michael Tunney, Prof Stuart Elborn (Centre for Infection and Immunity)

 __________________________________________________________________ 

 

The following project(s) are funded.

 

Preclinical development of simple and inexpensive depot injectable formulations for combination contraception and HIV prevention - Professor R Karl Malcolm and Dr Raj Thakur

The role of USP17 in EGFR signaling and as a potential novel target for therapy in colorectal cancer. - Dr James Burrows and Dr Sandra Van Schaeybroeck

 

 

DEL Studentships